Gapping up
News:
- TALS +7% (declares a special dividend)
- FRO +4% (reports fully funded acquisition of 24 modern VLCCs from Euronav NV (EURN)
- USO +3.3% (Crude oil futures spiked higher with Israel/Hamas war over the weekend)
- MIRM +2.8% (Presents LIVMARLI Clinical Data and Real-World Evidence at NASPGHAN)
- RNA +1.1% (reports new AOC 1001 Data Demonstrating Improvement in Multiple Additional Functional Endpoints and Favorable Long-term Safety and Tolerability in People with Myotonic Dystrophy Type 1)
- VTS +1% (announces several impactful acquisitions, revised 2023 guidance and preliminary 2024 outlook)
Analyst comments:
- ZS +1% (upgraded to Overweight from Equal Weight at Barclays)
- ARMK +0.9% (upgraded to Buy from Hold at Jefferies)